XML 38 R28.htm IDEA: XBRL DOCUMENT
v3.23.2

Earnings per Share (Tables) | 6 Months Ended
--- | ---
Jul. 29, 2023
Earnings Per Share [Abstract] |
Reconciliation Between Basic and Diluted Earnings per Share | The following is a reconciliation between basic and diluted weighted average shares outstanding:
|  | 13 Weeks Ended |  |  | 26 Weeks Ended |
(In thousands) |  | July 29, 2023 |  |  | July 30, 2022 |  |  | July 29, 2023 |  |  | July 30, 2022 |
Numerator: |  |  |  |  |  |  |  |  |  |  |  |
Net income (loss) and numerator for basic EPS |  | $ | 48,570 |  |  | $ | (42,466 | ) |  | $ | 67,022 |  |  | $ | (10,726 | )
Add: Interest expense, net of tax, related to the 2025 Notes (1) |  |  | - |  |  |  | — |  |  |  | 58 |  |  |  | — |
Numerator for diluted EPS |  | $ | 48,570 |  |  | $ | (42,466 | ) |  | $ | 67,080 |  |  | $ | (10,726 | )
Denominator: |  |  |  |  |  |  |  |  |  |  |  |
Denominator for basic EPS - weighted average shares |  |  | 195,329 |  |  |  | 180,189 |  |  |  | 195,214 |  |  |  | 174,544 |
Add: Dilutive effect of the 2025 Notes (1) (2) |  |  | — |  |  |  | — |  |  |  | 417 |  |  |  | — |
Add: Dilutive effect of stock options and non-vested restricted stock (3) |  |  | 774 |  |  |  | — |  |  |  | 1,191 |  |  |  | — |
Denominator for diluted EPS - adjusted weighted average shares |  |  | 196,103 |  |  |  | 180,189 |  |  |  | 196,822 |  |  |  | 174,544 |
Anti-dilutive shares (4) |  |  | 509 |  |  |  | 29,221 |  |  |  | 397 |  |  |  | 38,763 |
(1) During the 26 weeks ended July 30, 2022, the Company adopted ASU 2020-06. The Company utilizes the "if-converted" method of calculated diluted EPS. Refer to Note 2 to the Consolidated Financial Statements for additional information regarding the impact of the adoption of ASU 2020-06. (2) For the 13 and 26 weeks ended July 30, 2022, there were 25.3 million and 36.8 million potentially dilutive shares from the Company's 2025 Notes, respectively, that were excluded from the dilutive earnings per share calculation because the Company incurred a net loss for this period and their inclusion would be anti-dilutive. (3) For the 13 and 26 weeks ended July 30, 2022, there were 3.9 million and 1.9 million potentially dilutive equity awards, respectively, that were excluded from the diluted earnings per share calculation because the Company incurred a net loss for this period and their inclusion would be anti-dilutive. (4) For both periods presented, anti-dilutive shares relate to stock options and unvested restricted stock.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration